<PAPER>
  <mode2 name="20382639_arathi" hasDoc="yes" version="1258"/>
  <TITLE>
    <s sid="1">Benzo[a]pyrene diol epoxide stimulates an inflammatory response in normal human lung fibroblasts through a p53 and JNK mediated pathway <CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
  </TITLE>
  <ABSTRACT>
    <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-1">
      <s sid="2">Cellular responses to carcinogens are typically studied in transformed cell lines, which do not reflect the physiological status of normal tissues.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
      <s sid="3">To address this question, we have characterized the transcriptional program and cellular responses of human lung WI-38 fibroblasts upon exposure to the ultimate carcinogen benzo[a]pyrene diol epoxide (BPDE).<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/></s>
      <s sid="4">In contrast to observations in cell lines, we find that BPDE treatment induces a strong inflammatory response in these normal fibroblasts.<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
      <s sid="5">Whole-genome microarrays show induction of numerous inflammatory factors, including genes that encode interleukins (ILs), growth factors and enzymes related to prostaglandin synthesis and signaling.<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
      <s sid="6">Real-time reverse transcription&#8211;polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA) revealed a time- and dose-dependent-induced expression and production of cyclooxygenase 2, prostglandin E2 and IL1B, IL6 and IL8.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
      <s sid="7">In parallel, cell cycle progression and DNA repair processes were repressed, but DNA damage signaling was increased via p53-Ser15 phosphorylation and induced expression levels of GADD45A, CDKN1A, BTG2 and SESN1.<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
      <s sid="8">Network analysis suggested that activator protein 1 transcription factors may link the cell cycle response and DNA damage signaling with the inflammatory stress&#8211;response in these cells.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
      <s sid="9">We confirmed this hypothesis by showing that p53-dependent signaling through c-jun N-terminal kinase (JNK) led to increased cJun-Ser63 phosphorylation and that inhibition of JNK-mediated cJun activation using p53- or JNK-specific inhibitors significantly reduced IL gene expression and subsequent production of IL8.<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
      <s sid="10">This is the first demonstration that a strong inflammatory response is triggered in normal fibroblasts by BPDE and that this occurs through coordinated regulation with other cellular processes.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
    </p>
  </ABSTRACT>
  <BODY>
    <SEC>
      <TITLE>Introduction</TITLE>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-2">
        <s sid="11">Cigarette smoking is the primary cause of lung cancer and the lung inflammatory diseases emphysema and chronic bronchitis (<xref class="xref-bibr" href="#ref-1" rid="xref-ref-1-1">1</xref>,<xref class="xref-bibr" href="#ref-2" rid="xref-ref-2-1">2</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
        <s sid="12">Polycyclic aromatic hydrocarbons (PAHs) are among the many chemical components found in cigarette smoke that induce tumor formation and inflammation in experimental animals, supporting the notion that they play a significant role as etiological agents in human disease (<xref class="xref-bibr" href="#ref-3" rid="xref-ref-3-1">3</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
        <s sid="13">In fact, the International Agency for Research on Cancer reports that &#8764;15% of the carcinogenic compounds found in cigarette smoke are PAHs (<xref class="xref-bibr" href="#ref-1" rid="xref-ref-1-2">1</xref>); hence, the PAHs most probably contribute to the etiology of cancers associated with the well-known correlation between tobacco smoke and lung cancer (<xref class="xref-bibr" href="#ref-4" rid="xref-ref-4-1">4</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-3">
        <s sid="14">PAHs are readily metabolized to water-soluble compounds in a process that produces carcinogenic diol epoxide (DE) intermediates that react with nucleic acids, producing covalently modified bases in the genome (<xref class="xref-bibr" href="#ref-5" rid="xref-ref-5-1">5</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="15">In the case of high levels of PAH&#8211;DNA lesions, p53-associated responses block the cell cycle, providing an opportunity for the DNA repair machinery to restore genome integrity or direct the cell to undergo apoptosis (<xref class="xref-bibr" href="#ref-6" rid="xref-ref-6-1">6</xref>&#8211;<xref class="xref-bibr" href="#ref-9" rid="xref-ref-9-1">9</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="16">PAHs also activate production of inflammatory mediators through an aryl hydrocarbon receptor-dependent pathway, either directly or by downstream activation of phosphorylation-mediated signaling through mitogen-activated protein kinases that further stimulate stress-responsive transcription factors (<xref class="xref-bibr" href="#ref-10" rid="xref-ref-10-1">10</xref>&#8211;<xref class="xref-bibr" href="#ref-12" rid="xref-ref-12-1">12</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="17">Frequent exposure to agents that damage DNA can lead to chronic inflammation that has been linked to the progression of several pathological conditions, including cardiovascular and pulmonary diseases and cancer (<xref class="xref-bibr" href="#ref-13" rid="xref-ref-13-1">13</xref>,<xref class="xref-bibr" href="#ref-14" rid="xref-ref-14-1">14</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-4">
        <s sid="18">Gene profiling studies on PAH DE in different cell types, including normal epithelial cells and carcinoma cell lines, have been reported to show alterations in the expression of genes involved in the cell cycle, apoptosis, DNA repair and p53 pathways (<xref class="xref-bibr" href="#ref-15" rid="xref-ref-15-1">15</xref>&#8211;<xref class="xref-bibr" href="#ref-22" rid="xref-ref-22-1">22</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
        <s sid="19">However, the genome-wide response of lung fibroblasts to PAHs has not been studied.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
        <s sid="20">Lung fibroblasts confer structural support to the lung's connective tissue and play a role in stimulating and amplifying inflammatory signals, including those that arise as responses to cigarette smoke (<xref class="xref-bibr" href="#ref-23" rid="xref-ref-23-1">23</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="21">To examine this, we exposed normal human WI-38 lung fibroblasts to three different concentrations of benzo[a]pyrene diol epoxide (BPDE).<CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
        <s sid="22">Using whole-genome oligonucleotide microarrays to measure changes in gene expression, we found strong induction of genes involved in inflammatory response and parallel alterations in processes related to cell cycle regulation and DNA repair.<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
        <s sid="23">To identify the essential signaling events that mediate these responses, we performed directed assays of key members of multiple pathways to quantify messenger RNA (mRNA) and protein levels and to assess their activation status.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa3" novelty="None" advantage="None"/></s>
        <s sid="24">These experiments revealed that the mechanism underlying the response of normal lung fibroblasts to BPDE involves the coordinated regulation of multiple signaling pathways.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
      </p>
    </SEC>
    <SEC>
      <TITLE>Material and methods</TITLE>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Chemicals and reagents</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-5">
        <s sid="25">Racemic anti-BPDE [(&#177;)-7r,8t-dihydroxy-9t,10t-epoxy-7,8,9,10-tetrahydro benzo[a]pyrene] was obtained from the National Cancer Institute Chemical Carcinogen Reference Standard Repository (Kansas City, MO).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
        <s sid="26">Stock solutions of BPDE were prepared in dimethyl sulfoxide (DMSO) and stored at &#8722;20&#176;C.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
        <s sid="27">Protease Inhibitor Cocktail Set I, pifithrin-&#945; (PFT-&#945;) and c-jun N-terminal kinase (JNK) inhibitor VIII (JNKi) were from Calbiochem (Gibbstown, NJ).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
        <s sid="28">The antibodies against human p53 (DO-1) were from Santa Cruz Biotechnology (Santa Cruz, CA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
        <s sid="29">The antibodies against phospho-p53 (Ser15), phospho-p44/42 (Thr202/Tyr204), phospho-p38 (Thr180/Tyr182), phospho-stress-activated protein kinase/JNK (Thr183/Tyr185), stress-activated protein kinase/JNK (56G8), phospho-c-Jun (Ser63) and c-Jun (60A8) were from Cell Signaling Technology (Danvers, MA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
        <s sid="30">The antibodies against prostaglandin H2 and &#946;-tubulin were from Cayman Chemicals (Ann Arbor, MI) and NeoMarkers (Fremont, CA), respectively.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
        <s sid="31">Additional chemicals and reagents were from Sigma&#8211;Aldrich (St Louis, MO) and Fisher Scientific (Fair Lawn, NJ).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Cell culture</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-6">
        <s sid="32">Normal human diploid WI-38 lung fibroblasts, CCL-75&#8482;, were obtained from American Type Culture Collection (Manassas, VA) and grown in Eagle&#8217;s minimum essential medium supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and 1% penicillin/streptomycin (Invitrogen, Carlsbad CA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
        <s sid="33">WI-38 cells between passages 7 to 12 were used in all experiments to ensure proper cell characteristics as determined by American Type Culture Collection.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
        <s sid="34">Prior to BPDE exposure, 10<sup>6</sup> WI-38 cells were plated onto 10 cm dishes and incubated at 37&#176;C for 48 h.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
        <s sid="35">The cells were treated with BPDE as described previously, with some modifications (<xref class="xref-bibr" href="#ref-24" rid="xref-ref-24-1">24</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
        <s sid="36">The cells were incubated with BPDE (added in 10 &#956;l DMSO) for 20 min; 0.1% DMSO alone was added to cells to act as a control.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
        <s sid="37">The exposure medium was then replaced with fresh medium, and at selected time points, the medium was removed, and cells were washed with phosphate-buffered saline and harvested.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Cell viability</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-7">
        <s sid="38">WI-38 cells were exposed to BPDE as described above.<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
        <s sid="39">Cell viability was determined using a MTS assay in 96-well plates according to manufacturer's instruction (CellTiter 96 AQ<sub>ueous</sub> One Solution Cell Proliferation Assay; Promega, Madison, WI).<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
        <s sid="40">Senescence status was determined by staining for senescence-associated &#946;-galactosidase as described in ref. <xref class="xref-bibr" href="#ref-25" rid="xref-ref-25-1">25</xref>.<CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Western blot analysis</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-8">
        <s sid="41">Cells were lysed in ice-cold RIPA buffer (50 mM Tris&#8211;HCl, 150 mM NaCl, 1% NP-40, 0.1% sodium dodecyl sulfate and 0.5% Na-deoxycholate) with 1 mM phenylmethylsulfonyl fluoride, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM NaF and 10 &#956;l/ml of Protease Inhibitor Cocktail Set I. The lysate was boiled for 5 min in Laemmli buffer, and proteins were resolved by sodium dodecyl sulfate&#8211;polyacrylamide gel electrophoresis followed by immunoblotting.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/></s>
        <s sid="42">Proteins were visualized using ECL Plus&#8482; reagents (GE Healthcare, Piscataway, NJ).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">ELISA</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-9">
        <s sid="43">Cells seeded in six-well plates (2&#8201;&#215;&#8201;10<sup>5</sup> cells per well) were exposed to BPDE as described above.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/></s>
        <s sid="44">Extracellular concentrations were measured using a human IL8 (RayBiotech, Norcross, GA) or a human prostglandin E2 (PGE<sub>2</sub>) ELISA kit (Cayman Chemicals, Ann Arbor, MI).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/></s>
        <s sid="45">Absolute amounts were calculated using recombinant human IL8 and PGE<sub>2</sub> as standards and normalized to number of cells.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">RNA purification and real-time reverse transcription&#8211;polymerase chain reaction</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-10">
        <s sid="46">Total cellular RNA was prepared using the RNeasy Mini Kit (QIAGEN, Valencia, CA) and further treated with TURBO DNA-free&#8482; (Ambion, Austin, TX).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/></s>
        <s sid="47">Complementary DNA (cDNA) was generated using 1 &#956;g of total RNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) according to protocol.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/></s>
        <s sid="48">Subsequently, quantification of gene expression was performed in duplicates using iQ SYBR Green Supermix (Bio-Rad) with detection on an iCycler MyiQ (Bio-Rad).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/></s>
        <s sid="49">The reaction cycles used were 95&#176;C for 10 min and then 40 cycles at 95&#176;C for 15 s and 60&#176;C for 1 min followed by melt curve analysis.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/></s>
        <s sid="50">The primer sequences for ILs 1B, 6, 8, cyclooxygenase 2 (COX2) and GAPDH were taken from (<xref class="xref-bibr" href="#ref-26" rid="xref-ref-26-1">26</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="None" advantage="None"/></s>
        <s sid="51">Gene expression was further studied using a 96-well DNA damage signaling RT<sup>2</sup>Profiler&#8482; PCR array together with the associated ReactionReady&#8482; First Strand cDNA synthesis kit and real-time reverse transcription (RT<sup>2</sup>) Real-Time&#8482; SYBR Green PCR master mix (all from SAbiosciences, Frederick, MD).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/></s>
        <s sid="52">Relative gene expression quantification was based on the comparative threshold cycle method (2<sup>&#8722;&#916;&#916;Ct</sup>) (<xref class="xref-bibr" href="#ref-27" rid="xref-ref-27-1">27</xref>) with normalization of the raw data to the included housekeeping gene.<CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Microarray hybridization</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-11">
        <s sid="53">Experimental procedures were performed according to the GeneChip&#174; Expression Analysis Technical Manual using the One-Cycle Target Labeling and Control Reagents kit (Affymetrix, Santa Clara, CA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/></s>
        <s sid="54">Total RNA (5 &#956;g) was reverse transcribed into cDNA, which subsequently was used for synthesis of biotin-labeled complementary RNA.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/></s>
        <s sid="55">The Human Genome U133 Plus 2.0 microarray was then hybridized with 15 &#956;g fragmented complementary RNA, followed by washing and staining in a fluidics station (all from Affymetrix) according to standard protocols.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/></s>
        <s sid="56">Hybridization of total RNA from control and BPDE-treated cells was performed in triplicate.<CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Analysis of microarray data</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-12">
        <s sid="57">The microarrays were scanned using a GeneChip&#174; Scanner 3000 (Affymetrix) and subsequent image analysis was performed using Affymetrix GCOS software.<CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="None" advantage="None"/></s>
        <s sid="58">The resulting .cel files were normalized with the robust multichip average method (<xref class="xref-bibr" href="#ref-28" rid="xref-ref-28-1">28</xref>,<xref class="xref-bibr" href="#ref-29" rid="xref-ref-29-1">29</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met13" novelty="None" advantage="None"/></s>
        <s sid="59">Probe sets were filtered (<xref class="xref-bibr" href="#ref-30" rid="xref-ref-30-1">30</xref>) and subsequently analyzed for changes in expression using significance analysis of microarrays (SAM) (<xref class="xref-bibr" href="#ref-31" rid="xref-ref-31-1">31</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met14" novelty="None" advantage="None"/></s>
        <s sid="60">The raw data discussed in this publication have been deposited into National Center for Biotechnology Information Gene Expression Omnibus (Series GSE19510).<CoreSc1 atype="GSC" type="Met" conceptID="Met15" novelty="None" advantage="None"/></s>
        <s sid="61">Gene Ontology (GO) overrepresentation was analyzed by using GenMAPP/MAPPFinder version 2.1 (<xref class="xref-bibr" href="#ref-32" rid="xref-ref-32-1">32</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met16" novelty="None" advantage="None"/></s>
        <s sid="62">All genes identified as significantly affected by SAM were included in the analysis using a &#8805;2-fold change as analysis criteria.<CoreSc1 atype="GSC" type="Met" conceptID="Met17" novelty="None" advantage="None"/></s>
        <s sid="63">GO terms with a Z-score &gt; 2 were assumed to be significantly affected by the treatment.<CoreSc1 atype="GSC" type="Met" conceptID="Met18" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Network analysis</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-13">
        <s sid="64">A human protein&#8211;protein interaction network was obtained from the Human Protein Reference Database, release 7.<CoreSc1 atype="GSC" type="Met" conceptID="Met19" novelty="None" advantage="None"/></s>
        <s sid="65">Proteins whose gene expression significantly changed according to microarray analysis and were annotated with significantly enriched GO Biological Process terms (specified in <xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Table S5</xref>, available at Carcinogenesis Online) were selected from the network.<CoreSc1 atype="GSC" type="Met" conceptID="Met20" novelty="None" advantage="None"/></s>
        <s sid="66">This set was supplemented by genes/proteins identified as being involved in the response to BPDE in the current study (<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Table S6</xref> is available at Carcinogenesis Online), resulting in 153 proteins.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
        <s sid="67">This core network was supplemented with direct interactors (local 1-hop neighbors) from Human Protein Reference Database, resulting in 1339 proteins with 7778 interactions.<CoreSc1 atype="GSC" type="Met" conceptID="Met21" novelty="None" advantage="None"/></s>
        <s sid="68">In <xref class="xref-fig" href="#F6" rid="xref-fig-6-1">Figure 6</xref>, the network was reduced to only include significantly changed genes together with the supplemented nodes.<CoreSc1 atype="GSC" type="Met" conceptID="Met22" novelty="None" advantage="None"/></s>
        <s sid="69">To develop more specific response networks, three separate cell cycle, DNA repair and stress&#8211;response subnetworks with 121, 89 and 147 proteins, respectively, were created (found in <xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Figures S4</xref>&#8211;<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">S6</xref>, available at Carcinogenesis Online).<CoreSc1 atype="GSC" type="Goa" conceptID="Goa4" novelty="None" advantage="None"/></s>
      </p>
    </SEC>
    <SEC>
      <TITLE>Results</TITLE>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Normal human lung fibroblasts exposed to BPDE show significant changes in their global gene expression profile</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-14">
        <s sid="70">To test the effects of a PAH DE on lung fibroblasts, we used oligonucleotide microarrays representing &gt;38&#8201;000 well-characterized human genes to measure gene expression in WI-38 cells exposed to 0.1, 0.5 or 1 &#956;M BPDE for 24 h.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa5" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Exp" conceptID="Exp26" novelty="None" advantage="None"/></s>
        <s sid="71">We note that exposure to 1 &#956;M BPDE for 24 or 48 h led to a 20% decrease in viability, whereas lower doses of BPDE (0.1 and 0.01 &#956;M) were minimally cytotoxic with a &lt;10% decrease in viability (<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Figure S1</xref> is available at Carcinogenesis Online).<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
        <s sid="72">Detection call filtering followed by SAM identified 1332 genes whose expression was significantly changed following exposure to at least one concentration of BPDE when compared with control cells (<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Table S1</xref> is available at Carcinogenesis Online).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
        <s sid="73">A significant change in gene expression was defined as &#8805;2-fold change in expression with &lt;10% false discovery rate (FDR).<CoreSc1 atype="GSC" type="Met" conceptID="Met23" novelty="None" advantage="None"/></s>
        <s sid="74">Exposure to 0.1, 0.5 or 1 &#956;M BPDE resulted in 384, 972 and 837 differentially expressed genes, respectively (<xref class="xref-fig" href="#F1" rid="xref-fig-1-1">Figure 1A</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
        <s sid="75">Of these, 37 genes were upregulated and 151 genes were downregulated in response to all doses of BPDE.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/></s>
        <s sid="76">Hierarchical clustering revealed a significant similarity in responses induced by the two higher doses when compared with the lower dose of 0.1 &#956;M BPDE (<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Figure S2</xref>, is available at Carcinogenesis Online).<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">BPDE induces changes in gene expression related to cell cycle regulation, DNA repair and cell&#8211;cell signaling</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-16">
        <s sid="77">To elucidate the fundamental cellular processes affected in WI-38 cells following exposure to BPDE, we examined functional annotations of genes with significant changes in expression using GO Biological Process terms (written in italic).<CoreSc1 atype="GSC" type="Goa" conceptID="Goa6" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met24" novelty="None" advantage="None"/></s>
        <s sid="78">Downregulated genes were mainly involved in mitosis, cell cycle checkpoints, spindle organization and biogenesis, DNA replication and DNA repair, among others.<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
        <s sid="79">Upregulated genes were involved in nucleosome assembly, cell proliferation and extracellular processes such as cell&#8211;cell signaling and stress, inflammatory and immune responses.<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
        <s sid="80">Both negative and positive regulators of proliferation were among the induced genes involved in cell proliferation; induced expression of cytokines and growth factors were mainly responsible for the effect on cell&#8211;cell signaling and the stress&#8211;responses and the effect on nucleosome assembly was principally a function of upregulation of histone genes.<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
        <s sid="81">A complete accounting of significantly affected GO terms and associated genes are provided in <xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Figure S3</xref> and <xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">Table S2</xref> (available at Carcinogenesis Online).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-17">
        <s sid="82">To identify dose-dependent effects of BPDE on gene expression, we analyzed GO functional annotations for gene clusters in <xref class="xref-fig" href="#F1" rid="xref-fig-1-2">Figure 1A</xref>.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa7" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met25" novelty="None" advantage="None"/></s>
        <s sid="83">Nucleosome assembly and metabolism were positively affected by all three BPDE concentrations, but stress, inflammatory and immune response processes were only upregulated following exposure to 0.5 or 1 &#956;M BPDE.<CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/></s>
        <s sid="84">All three BPDE doses led to downregulation of processes related to the cell cycle and intracellular organization (i.e. cytoskeleton and chromosome organization).<CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/></s>
        <s sid="85">These results indicate that the threshold dose of BPDE required to produce an inflammatory response is higher than that required to shut down cell cycle related processes in lung fibroblasts.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">DNA repair genes show time- and dose-dependent downregulation in response to BPDE</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-18">
        <s sid="86">While microarray results showed that genes involved in DNA damage repair were generally downregulated, WI-38 cells are capable of repairing DNA adducts formed by BPDE in a biphasic manner, with &#8764;50% of the adducts removed within 6 h following exposure (K.Dreij, N.E.Geacintov and D.A.Scicchitano, unpublished results).<CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/></s>
        <s sid="87">This is in agreement with earlier studies looking at repair of DNA adducts derived from BPDE in cellular systems (<xref class="xref-bibr" href="#ref-24" rid="xref-ref-24-2">24</xref>,<xref class="xref-bibr" href="#ref-33" rid="xref-ref-33-1">33</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="88">Two genes directly involved in DNA repair were induced by BPDE: RRM2B (encoding ribonucleotide reductase RIR2B) and POLG2 (encoding the mitochondrial DNA polymerase accessory subunit DPOG2).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/></s>
        <s sid="89">In addition, exposure to 0.5 or 1 &#956;M BPDE significantly induced genes whose products are involved in suppressing cell proliferation and the cell cycle in response to DNA damage, including BTG2, SESN1, CDKN1A and GADD45A.<CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-19">
        <s sid="90">To confirm and extend our microarray results, we used a real-time reverse transcription (RT<sup>2</sup>)&#8211;polymerase chain reaction (PCR) array covering 84 genes involved in DNA damage signaling and repair to study the effects of BPDE on their expression in more detail.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa8" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met26" novelty="None" advantage="None"/></s>
        <s sid="91">Since the two higher doses induced similar overall expression responses based on microarray data, we extended the range of exposure to 0.01, 0.1 and 1 &#956;M BPDE for 6, 24 and 48 h.<CoreSc1 atype="GSC" type="Met" conceptID="Met27" novelty="None" advantage="None"/></s>
        <s sid="92">The results revealed both time- and dose-dependent downregulation of expression, with 22 genes significantly downregulated (&#8805;2-fold and P&#8201;&lt;&#8201;0.05; <xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Table S3</xref> is available at Carcinogenesis Online).<CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/></s>
        <s sid="93">Consistent with microarray results, only BTG2 and GADD45A were upregulated in response to 1 &#956;M BPDE; these showed increased expression by 6 h and sustained levels of induction up to 48 h posttreatment.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/></s>
        <s sid="94">(Lower doses did not affect their expression levels significantly.) Although the RT<sup>2</sup>&#8211;PCR showed a more pronounced effect the overall results were in good agreement with the microarray analysis (<xref class="xref-fig" href="#F1" rid="xref-fig-1-3">Figure 1B</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Factors involved in prostaglandin and IL signaling exhibit time- and dose-dependent induction of mRNA and protein levels</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-20">
        <s sid="95">BPDE's most striking effect on gene expression in WI-38 cells was the upregulation of genes involved in cell&#8211;cell signaling, the immune response and the inflammatory response.<CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/></s>
        <s sid="96">Among the induced genes were ILs 6, 8 and 11; matrix metallopeptidases 1, 3 and 10; growth factors BMP2, FGF9 and GDF15 and genes involved in prostaglandin synthesis and its regulation, COX2, PTGES and EDN1.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/></s>
        <s sid="97">Due to the physiological importance of IL8 and the COX2-driven prostaglandins (PGE<sub>2</sub>) as regulators of inflammatory signaling, we performed a more in-depth analysis of the time&#8211;response and dose&#8211;response of IL8 and COX2 using both RT<sup>2</sup>&#8211;PCR and ELISA.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met28" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-21">
        <s sid="98">In RT<sup>2</sup>&#8211;PCR assays, COX2 mRNA was repressed during the first 6 h after BPDE exposure, followed by induced expression at 24 and 48 h; however, only the two highest BPDE doses led to extensive upregulation, with a maximal 15-fold increase in mRNA at 24 and 48 h (<xref class="xref-fig" href="#F2" rid="xref-fig-2-1">Figure 2A</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/></s>
        <s sid="99">This result was consistent with the microarray results, which likewise showed a significant increase in COX2 mRNA only at the two higher doses (3.9-fold and 12.8-fold, respectively).<CoreSc1 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/></s>
        <s sid="100">PGE<sub>2</sub> levels measured by ELISA also increased over time, consistent with microarray and RT<sup>2</sup>&#8211;PCR results.<CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/></s>
        <s sid="101">The highest concentration of extracellular PGE<sub>2</sub> was detected from cells exposed to 0.1 &#956;M BPDE at 24 h (3.7-fold increase, P&#8201;&lt;&#8201;0.05; <xref class="xref-fig" href="#F2" rid="xref-fig-2-2">Figure 2C</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res22" novelty="None" advantage="None"/></s>
        <s sid="102">Exposure to the highest dose of BPDE (1 &#956;M) led to a slower response that peaked after 48 h (4.4-fold increase, P&#8201;&lt;&#8201;0.05).<CoreSc1 atype="GSC" type="Res" conceptID="Res23" novelty="None" advantage="None"/></s>
        <s sid="103">This elevation in extracellular PGE<sub>2</sub> was not due to an increase in the amount of enzyme responsible for its synthesis since western blot analysis using antibodies against prostaglandin G/H synthase 2 (prostaglandin H2, encoded by COX2) showed no increase in protein levels (data not shown).<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-23">
        <s sid="104">In the case of IL8, RT<sup>2</sup>&#8211;PCR assays showed a soaring 309-fold elevation in mRNA levels at 24 h followed by a 44.5-fold elevation at 48 h after exposure to 1 &#956;M BPDE when compared with DMSO controls (all P&#8201;&lt;&#8201;0.05; <xref class="xref-fig" href="#F2" rid="xref-fig-2-3">Figure 2B</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res24" novelty="None" advantage="None"/></s>
        <s sid="105">Microarray results displayed a parallel but less dramatic pattern, with significantly increased expression at 24 h of 11.2-fold and 41.9-fold in response to 0.5 and 1 &#956;M BPDE, respectively.<CoreSc1 atype="GSC" type="Res" conceptID="Res25" novelty="None" advantage="None"/></s>
        <s sid="106">Extracellular IL8 protein levels were also significantly elevated in response to BPDE treatment as measured by ELISA (<xref class="xref-fig" href="#F2" rid="xref-fig-2-4">Figure 2D</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res26" novelty="None" advantage="None"/></s>
        <s sid="107">Exposure to 1 &#956;M BPDE produced the largest effect on IL8 excretion, displaying maximum levels of &#8764;5-fold over control (P&#8201;&lt;&#8201;0.05) after 48 h.<CoreSc1 atype="GSC" type="Res" conceptID="Res27" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-24">
        <s sid="108">A secretory phenotype consisting of increased signaling of inflammatory mediators has been associated with senescence in response to genotoxic stress in normal human fibroblasts (<xref class="xref-bibr" href="#ref-34" rid="xref-ref-34-1">34</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
        <s sid="109">To test whether the increased signaling of inflammatory mediators in this study was coupled with senescence, exposed cells were stained for senescence-associated &#946;-galactosidase (<xref class="xref-bibr" href="#ref-25" rid="xref-ref-25-2">25</xref>).<CoreSc1 atype="GSC" type="Goa" conceptID="Goa9" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met29" novelty="None" advantage="None"/></s>
        <s sid="110">The highest dose of BPDE (1 &#956;M) induced senescence in a very low number of cells (&#8804;4%), indicating that the observed increase in signaling of inflammatory mediators was not related to senescence (<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Table S4</xref> is available at Carcinogenesis Online).<CoreSc1 atype="GSC" type="Res" conceptID="Res28" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">BPDE induces p53-dependent signaling through JNK with subsequent activation of cJun</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-25">
        <s sid="111">To identify the regulatory pathways responsible for gene expression changes in WI-38 cells following BPDE exposure, we measured levels and activation status of p53 and mitogen-activated protein kinase proteins, including phosphorylation of p53 at Ser15, which is mediated by ataxia telangiectasia mutated and ataxia telangiectasia and Rad3 related in response to DNA damage and promotes activation of p53-dependent pathways (<xref class="xref-bibr" href="#ref-35" rid="xref-ref-35-1">35</xref>,<xref class="xref-bibr" href="#ref-36" rid="xref-ref-36-1">36</xref>).<CoreSc1 atype="GSC" type="Goa" conceptID="Goa10" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met30" novelty="None" advantage="None"/></s>
        <s sid="112">As expected, we observed an increase in both p53 protein levels and phosphorylation of Ser15 after 24 and 48 h exposure to 0.5 and 1 &#956;M BPDE, but not at 6 h (<xref class="xref-fig" href="#F3" rid="xref-fig-3-1">Figure 3A and B</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/></s>
        <s sid="113">The lower dose of 0.1 &#956;M BPDE resulted in increased levels of p53 protein, but no detectable Ser15 phosphorylation, after 24 h.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/></s>
        <s sid="114">JNK protein levels remained constant after exposing WI-38 cells to BPDE, but increased JNK Thr183/Tyr185 phosphorylation was detected beginning 1 h after treatment (<xref class="xref-fig" href="#F3" rid="xref-fig-3-2">Figure 3A</xref>) and was observed up to 24 and 48 h after exposure to 0.5 and 1 &#956;M BPDE (<xref class="xref-fig" href="#F3" rid="xref-fig-3-3">Figure 3B</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/></s>
        <s sid="115">Phosphorylation status of ERK and p38 was basically unaffected (<xref class="xref-fig" href="#F3" rid="xref-fig-3-4">Figure 3A</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-27">
        <s sid="116">We further investigated whether the signaling through JNK was p53-dependent and would therefore result in downstream activation of the activator protein 1 (AP-1) transcription factor cJun.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
        <s sid="117">Indeed, pretreatment of WI-38 cells with PFT-&#945; and JNKi&#8212;which inhibit p53 and JNK (<xref class="xref-bibr" href="#ref-37" rid="xref-ref-37-1">37</xref>&#8211;<xref class="xref-bibr" href="#ref-40" rid="xref-ref-40-1">40</xref>)&#8212;strongly reduced signaling through JNK and cJun (Ser63), respectively (<xref class="xref-fig" href="#F4" rid="xref-fig-4-1">Figure 4A</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res29" novelty="None" advantage="None"/></s>
        <s sid="118">Based on densitometric analysis, the inhibitors did not affect the extent of JNK and cJun phosphorylation at 6 h.<CoreSc1 atype="GSC" type="Res" conceptID="Res30" novelty="None" advantage="None"/></s>
        <s sid="119">However, signaling was significantly reduced at the later time points, displaying &gt;2-fold reduction of phosphorylation for both JNK and cJun at 48 h (39&#8201;&#177;&#8201;6% and 42&#8201;&#177;&#8201;10%, respectively, P&#8201;&lt; 0.05; <xref class="xref-fig" href="#F4" rid="xref-fig-4-2">Figure 4B</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res31" novelty="None" advantage="None"/></s>
      </p>
      <h3 xmlns:xhtml="http://www.w3.org/1999/xhtml">Increased IL expression and signaling are mediated through a p53 and JNK signaling pathway</h3>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-29">
        <s sid="120">We next studied the effect of interrupted p53 and JNK signaling on COX2 and ILs 1B, 6 and 8 signaling using RT<sup>2</sup>&#8211;PCR and ELISA.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met31" novelty="None" advantage="None"/></s>
        <s sid="121">BPDE induction of COX2 mRNA remained the same or increased when cells were pretreated with JNKi and PFT-&#945; (<xref class="xref-fig" href="#F5" rid="xref-fig-5-1">Figure 5A</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/></s>
        <s sid="122">In contrast, inhibition of p53 and JNK significantly reduced the induction of IL mRNA levels in response to BPDE treatment.<CoreSc1 atype="GSC" type="Res" conceptID="Res32" novelty="None" advantage="None"/></s>
        <s sid="123">While IL8 expression still was induced in WI-38 cells treated with inhibitor plus BPDE, mRNA levels were significantly lower compared with cells exposed to BPDE alone at 24 and 48 h (P &lt; 0.05; <xref class="xref-fig" href="#F5" rid="xref-fig-5-2">Figure 5A</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res33" novelty="None" advantage="None"/></s>
        <s sid="124">Blocking the signaling through p53 and JNK significantly reduced mRNA levels of IL1B at 24 and 48 h (P&#8201;&lt;&#8201;0.05), similarly the expression of IL6 was significantly reduced by JNKi at 6 h and by both inhibitors at 24 h (P&#8201;&lt;&#8201;0.05).<CoreSc1 atype="GSC" type="Res" conceptID="Res34" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-31">
        <s sid="125">Pretreatment with inhibitor also resulted in a significant reduction of extracellular IL protein levels, further confirming their negative effect on IL signaling: in the presence of either PFT-&#945; or JNKi, extracellular IL8 was reduced to the same level as controls at 24 and 48 h (<xref class="xref-fig" href="#F5" rid="xref-fig-5-3">Figure 5B</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res35" novelty="None" advantage="None"/></s>
        <s sid="126">These results clearly show that signaling through p53 and JNK plays a major role in the induction of IL expression and signaling in response to BPDE treatment of normal lung fibroblasts.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
      </p>
    </SEC>
    <SEC>
      <TITLE>Discussion</TITLE>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-32">
        <s sid="127">Fibroblasts synthesize and maintain stromal support for most renewable epithelial tissue, including the lungs, where they modulate the inflammatory response to many inhaled agents such as cigarette smoke that contains a wide array of PAHs (<xref class="xref-bibr" href="#ref-23" rid="xref-ref-23-2">23</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
        <s sid="128">Moreover, lung fibroblasts metabolize PAHs to DEs, leading to the formation of PAH&#8211;DNA adducts (<xref class="xref-bibr" href="#ref-7" rid="xref-ref-7-1">7</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
        <s sid="129">The studies reported here using genome-wide expression analysis show that BPDE, the ultimate carcinogenic metabolite of the PAH benzo[a]pyrene (BP), induces a dose-dependent inflammatory response in normal human lung fibroblasts that operates parallel to downregulation of DNA repair and cell cycle progression.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
        <s sid="130">Furthermore, BPDE induces the activation of JNK, which in turn increases the expression of several ILs.<CoreSc1 atype="GSC" type="Res" conceptID="Res36" novelty="None" advantage="None"/></s>
        <s sid="131">Abrogation of the JNK pathway using p53- and JNK-specific inhibitors dramatically reduces gene expression and subsequent production of ILs 1B, 6 and 8.<CoreSc1 atype="GSC" type="Res" conceptID="Res37" novelty="None" advantage="None"/></s>
        <s sid="132">This is the first time such a strong inflammatory response has been observed in response to a PAH DE in human lung fibroblasts.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-33">
        <s sid="133">While cellular inflammatory responses to cigarette smoke and PAHs such as BP have been reported, there are important differences in how inflammation is mediated upon exposure to a DE metabolite like BPDE.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot4" novelty="None" advantage="None"/></s>
        <s sid="134">First, inflammatory responses to BP and other PAHs are mediated through aryl hydrocarbon receptor-dependent signaling (<xref class="xref-bibr" href="#ref-10" rid="xref-ref-10-2">10</xref>&#8211;<xref class="xref-bibr" href="#ref-12" rid="xref-ref-12-2">12</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
        <s sid="135">BPDE interacts with the aryl hydrocarbon receptor to less extent and is furthermore a poor inducer of downstream metabolic events because of its short intracellular half-life compared with BP (<xref class="xref-bibr" href="#ref-41" rid="xref-ref-41-1">41</xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
        <s sid="136">Furthermore, PAH metabolism via cytochrome P450 (CYP450) or aldo&#8211;keto reductase generates reactive oxygen species (ROS), which are known to induce inflammatory responses (<xref class="xref-bibr" href="#ref-42" rid="xref-ref-42-1">42</xref>&#8211;<xref class="xref-bibr" href="#ref-44" rid="xref-ref-44-1">44</xref>); however, BPDE does not contribute to ROS production (<xref class="xref-bibr" href="#ref-44" rid="xref-ref-44-2">44</xref>,<xref class="xref-bibr" href="#ref-45" rid="xref-ref-45-1">45</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
        <s sid="137">The analysis reported here supports the limited contribution of ROS to the BPDE inflammatory response.<CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/></s>
        <s sid="138">Transcriptional changes in processes related to ROS or oxidative stress remain unaffected by BPDE treatment, whereas the parent PAH BP induces the expression of genes related to the response to ROS and oxidative stress (<xref class="xref-bibr" href="#ref-46" rid="xref-ref-46-1">46</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
        <s sid="139">Consequently, BPDE should induce inflammatory responses by pathways that operate independently from those induced by ROS.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-34">
        <s sid="140">Increases in ILs are implicated in the development of several diseases related to inflammation, including the progression of lung cancer (reviewed in ref. <xref class="xref-bibr" href="#ref-47" rid="xref-ref-47-1">47</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
        <s sid="141">This may be important since IL8 expression in normal bronchial and amnion epithelial cells increases in response to BPDE (<xref class="xref-bibr" href="#ref-20" rid="xref-ref-20-1">20</xref>,<xref class="xref-bibr" href="#ref-22" rid="xref-ref-22-2">22</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
        <s sid="142">However, the intracellular signaling pathways regulating the induction of IL expression in response to BPDE have not been reported.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot5" novelty="None" advantage="None"/></s>
        <s sid="143">The results presented here show that increased IL signaling mediates the inflammatory response in human lung fibroblasts following exposure to BPDE.<CoreSc1 atype="GSC" type="Res" conceptID="Res38" novelty="None" advantage="None"/></s>
        <s sid="144">Furthermore, the response is regulated through a pathway that includes p53 and JNK, leading to transactivation of cJun.<CoreSc1 atype="GSC" type="Res" conceptID="Res39" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-35">
        <s sid="145">Our data also show that concomitant induction of COX2 in these cells leads to increased prostaglandin production independently of regulation through p53 and JNK.<CoreSc1 atype="GSC" type="Res" conceptID="Res40" novelty="None" advantage="None"/></s>
        <s sid="146">These results are consistent with the findings that BPDE-induced COX2 expression is mediated through nuclear factor-kappaB signaling in mouse epidermal cells and rat astrocytes (<xref class="xref-bibr" href="#ref-48" rid="xref-ref-48-1">48</xref>,<xref class="xref-bibr" href="#ref-49" rid="xref-ref-49-1">49</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Res" conceptID="Res41" novelty="None" advantage="None"/></s>
        <s sid="147">High expression levels of COX2 and the formation of prostaglandins are implicated in cancer development.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
        <s sid="148">Hence, it is not necessarily surprising that COX2 inhibitors are associated with lowering the risk of certain cancers, including colorectal cancer (<xref class="xref-bibr" href="#ref-50" rid="xref-ref-50-1">50</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-36">
        <s sid="149">To extend our analysis and visualize the results for WI-38 fibroblast exposure to BPDE, we used publicly available data to construct an in silico protein&#8211;protein interaction (PPI) network for annotated genes whose expression was most affected by BPDE.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa11" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met32" novelty="None" advantage="None"/></s>
        <s sid="150">These included primarily genes related to the cell cycle, DNA repair and stress&#8211;response (<xref class="xref-fig" href="#F6" rid="xref-fig-6-2">Figure 6</xref>; <xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">supplementary Figures S4</xref>&#8211;<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">S6</xref> is available at Carcinogenesis Online).<CoreSc1 atype="GSC" type="Res" conceptID="Res42" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-38">
        <s sid="151">For the cell cycle network, genes involved in replication and mitosis were downregulated and genes that inhibit G<sub>1</sub>/S and G<sub>2</sub>/M transitions were upregulated in our experiments.<CoreSc1 atype="GSC" type="Res" conceptID="Res43" novelty="None" advantage="None"/></s>
        <s sid="152">These aggregate changes result in an overall slowing or arresting of cell cycle progression, which is consistent with previous reports (<xref class="xref-bibr" href="#ref-16" rid="xref-ref-16-1">16</xref>,<xref class="xref-bibr" href="#ref-19" rid="xref-ref-19-1">19</xref>,<xref class="xref-bibr" href="#ref-21" rid="xref-ref-21-1">21</xref>,<xref class="xref-bibr" href="#ref-22" rid="xref-ref-22-3">22</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/></s>
        <s sid="153">Cellular responses to DNA damage are frequently mediated through pausing or stalling the cell cycle, allowing time for repair or permitting apoptosis or senescence to occur when damage is extensive.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
        <s sid="154">Nonetheless, in WI-38 lung fibroblasts exposed to BPDE, most genes involved in DNA repair are generally downregulated or relatively unaffected (<xref class="xref-fig" href="#F6" rid="xref-fig-6-3">Figure 6</xref>), which is consistent with results in other BPDE-exposed cells (<xref class="xref-bibr" href="#ref-17" rid="xref-ref-17-1">17</xref>&#8211;<xref class="xref-bibr" href="#ref-19" rid="xref-ref-19-2">19</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res44" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
        <s sid="155">For nucleotide excision repair, which is the main DNA repair pathway that operates on PAH-damaged DNA, the primary regulatory mechanism may well involve rapid posttranslational modifications and PPIs as opposed to altered transcription (<xref class="xref-bibr" href="#ref-51" rid="xref-ref-51-1">51</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-39">
        <s sid="156">Several stress&#8211;response mediators found in the PPI network (<xref class="xref-fig" href="#F6" rid="xref-fig-6-4">Figure 6</xref>) physically interact with factors related to the cell cycle and DNA repair, including GADD45B and the AP-1 family members ATF3 and FOS.<CoreSc1 atype="GSC" type="Res" conceptID="Res45" novelty="None" advantage="None"/></s>
        <s sid="157">Activation of AP-1 occurs through increased expression of FOS and the phosphorylation of cJun (<xref class="xref-bibr" href="#ref-52" rid="xref-ref-52-1">52</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
        <s sid="158">The Fos&#8211;Jun complex binds DNA with high affinity and induces the expression of many of the inflammatory mediators in this network, including the ILs, thus connecting the cell cycle and DNA repair with the stress&#8211;response through transcriptional regulation (not represented in the PPI network) (<xref class="xref-bibr" href="#ref-53" rid="xref-ref-53-1">53</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-40">
        <s sid="159">The data reported here emphasize that caution should be used in extrapolating results from transformed cells to normal cells following exposure to DNA damaging agents.<CoreSc1 atype="GSC" type="Con" conceptID="Con10" novelty="None" advantage="None"/></s>
        <s sid="160">The strong inflammatory response observed in normal lung fibroblasts after BPDE exposure agrees with findings from genome-wide studies of other normal human cell types (<xref class="xref-bibr" href="#ref-20" rid="xref-ref-20-2">20</xref>,<xref class="xref-bibr" href="#ref-22" rid="xref-ref-22-4">22</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Goa" conceptID="Goa12" novelty="None" advantage="None"/></s>
        <s sid="161">However, these results are in contrast with transformed or carcinoma cell lines which exhibit a much less pronounced upregulation of inflammatory mediators (<xref class="xref-bibr" href="#ref-18" rid="xref-ref-18-1">18</xref>,<xref class="xref-bibr" href="#ref-19" rid="xref-ref-19-3">19</xref>,<xref class="xref-bibr" href="#ref-21" rid="xref-ref-21-2">21</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
        <s sid="162">Similarly, changes in histone gene expression in response to BPDE from this and other studies show induction in normal cells and repression in carcinoma cell lines (<xref class="xref-bibr" href="#ref-19" rid="xref-ref-19-4">19</xref>&#8211;<xref class="xref-bibr" href="#ref-22" rid="xref-ref-22-5">22</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
        <s sid="163">These differences are not unique to BPDE since gene expression responses related to CYP450 metabolism, cell cycle checkpoints and apoptosis signaling also differ between normal and corresponding transformed cells following ultraviolet B irradiation and exposure to cigarette smoke condensate (<xref class="xref-bibr" href="#ref-54" rid="xref-ref-54-1">54</xref>,<xref class="xref-bibr" href="#ref-55" rid="xref-ref-55-1">55</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-41">
        <s sid="164">Cell senescence is one of the many mechanisms that an organism employs for tumor suppression in response to genotoxic exposure (<xref class="xref-bibr" href="#ref-56" rid="xref-ref-56-1">56</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
        <s sid="165">Moreover, senescence leads to increased secretion of inflammatory mediators (<xref class="xref-bibr" href="#ref-34" rid="xref-ref-34-2">34</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
        <s sid="166">In fact, the addition of antioxidants diminishes senescence in ultraviolet B and bisulfan-treated cells (<xref class="xref-bibr" href="#ref-57" rid="xref-ref-57-1">57</xref>,<xref class="xref-bibr" href="#ref-58" rid="xref-ref-58-1">58</xref>), which provides persuasive evidence that ROS are involved in triggering senescence.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
        <s sid="167">WI-38 lung fibroblasts display a similar secretory phenotype in response to BPDE exposure, but there is no associated significant increase in senescence due to the fact that BPDE does not participate in the production of ROS.<CoreSc1 atype="GSC" type="Res" conceptID="Res46" novelty="None" advantage="None"/></s>
        <s sid="168">This supports the findings that oxidative stress and the formation of ROS are important contributing factors in activating senescence signaling in response to DNA damage.<CoreSc1 atype="GSC" type="Con" conceptID="Con11" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-42">
        <s sid="169">In conclusion, the studies reported here show that PAH DEs contribute to inflammatory responses in fibroblasts, independent of senescence and any metabolic byproducts such as ROS that are made during biotransformation of the parent PAH to the ultimate carcinogenic DE.<CoreSc1 atype="GSC" type="Con" conceptID="Con12" novelty="None" advantage="None"/></s>
        <s sid="170">Therefore, our current study shows that PAH DEs cannot only induce carcinogenesis through the formation of DNA damage but also by activating intracellular and intercellular signaling, inducing tumor-promoting inflammation.<CoreSc1 atype="GSC" type="Con" conceptID="Con13" novelty="None" advantage="None"/></s>
        <s sid="171">These results have important implications concerning the stromal&#8211;epithelial interactions in lung cancer development as a result of PAH exposure.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot6" novelty="None" advantage="None"/></s>
      </p>
    </SEC>
    <SEC>
      <TITLE>Supplementary material</TITLE>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-43">
        <s sid="172"><xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">Supplementary Figures S1</xref>&#8211;<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">S6</xref> and <xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">Tables S1</xref>&#8211;<xref href="http://carcin.oxfordjournals.org/cgi/content/full/bgq073/DC1">S6</xref> can be found at <xref href="http://carcin.oxfordjournals.org/">http://carcin.oxfordjournals.org/</xref></s>
      </p>
    </SEC>
    <SEC>
      <TITLE>Funding</TITLE>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-44">
        <s sid="173">National Institutes of Health (ES010581) to D.A.S.</s>
      </p>
    </SEC>
    <SEC>
      <TITLE>Acknowledgments</TITLE>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-64">
        <s sid="174">We thank the members of the Scicchitano laboratory John Burns and Laura Cartularo for critical reading and evaluation of the manuscript.</s>
        <s sid="175">The (&#177;)-7r,8t-dihydroxy-9t,10t-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene was obtained from the National Cancer Institute Chemical Carcinogen Reference Standard Repository.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp27" novelty="None" advantage="None"/></s>
      </p>
      <p xmlns:xhtml="http://www.w3.org/1999/xhtml" id="p-65">
        <s sid="176">Conflict of Interest Statement: None declared.</s>
      </p>
    </SEC>
    <SEC>
      <TITLE>Footnotes</TITLE>
    </SEC>
    <SEC>
      <TITLE>References</TITLE>
    </SEC>
  </BODY>
</PAPER>